These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 10741260)
21. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366 [TBL] [Abstract][Full Text] [Related]
22. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678 [TBL] [Abstract][Full Text] [Related]
23. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Rashid AB; Grossniklaus HE Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990 [TBL] [Abstract][Full Text] [Related]
24. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients. Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465 [TBL] [Abstract][Full Text] [Related]
26. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444 [TBL] [Abstract][Full Text] [Related]
27. [The morphological forms of malignant uveal melanoma]. Simionescu C Oftalmologia; 1993; 37(1):3-11. PubMed ID: 8507607 [TBL] [Abstract][Full Text] [Related]
28. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma. Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926 [TBL] [Abstract][Full Text] [Related]
29. Increased stromal cell-derived factor-1 concentration levels in aqueous from patients with uveal melanoma. Zerbini G; Colucci A; Maestroni A; Miserocchi E; Bandello F; Modorati G Melanoma Res; 2012 Feb; 22(1):98-9. PubMed ID: 22228277 [No Abstract] [Full Text] [Related]
30. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288 [TBL] [Abstract][Full Text] [Related]
31. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta. Woodward JK; Elshaw SR; Murray AK; Nichols CE; Cross N; Laws D; Rennie IG; Sisley K Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3144-52. PubMed ID: 12356817 [TBL] [Abstract][Full Text] [Related]
32. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
33. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults. Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382 [TBL] [Abstract][Full Text] [Related]